Lung transplantation for primary pulmonary hypertension

Clinics in Chest Medicine

Volumn 22, Issue 3, 2001, Pages 583-593

  Trulock, Elbert P ^a,b,c,d  

^a Department of Medicine ^*  (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUMC 3876   (United States)

^d BARNES JEWISH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRAFT INFECTION; GRAFT REJECTION; HUMAN; LUNG TRANSPLANTATION; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; SURVIVAL RATE; TREATMENT INDICATION;

EID: 0034804729     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-5231(05)70293-8     Document Type: Article

References (77)

1. Isolated lung transplantation for patients with Eisenmenger's Syndrome
2. Effect of cardiopulmonary bypass on early graft dysfunction in clinical lung transplantation
3. Evaluation of long-term results of single lung versus heart-lung transplantation for emphysema
4. Indications for and results of single, bilateral and heart-lung transplantation for pulmonary hypertension
5. Obliterative bronchiolitis after lung and heart-lung transplantation: An analysis of risk factors and management
6. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension
7. Evaluation of transbronchial lung biopsy specimens in the diagnosis of bronchiolitis obliterans after lung transplantation
8. Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension
9. Comparative outcome of heart-lung and lung transplantation for pulmonary hypertension
10. Survival in patients with primary pulmonary hypertension: Results from a national prospective registry
11. The impact of cytolytic therapy on bronchiolitis obliterans syndrome
12. Long-term results, hemodynamics and complications after combined heart and lung transplantation
13. Efficacy of total lymphoid irradiation for chronic allograft rejection following bilateral lung transplantation
14. Methotrexate can halt the progression of bronchiolitis obliterans syndrome in lung transplant recipients
15. An economic analysis of heart-lung transplantation. Costs, insurance coverage and reimbursement
16. Single- versus double-lung transplantation for pulmonary hypertension
17. Risk factors for the development of obliterative bronchiolitis after lung transplantation
18. Obliterative bronchiolitis after heart-lung transplantation: Apparent arrest by augmented immunosuppression
19. A prospective randomized trial of FK 506 versus cyclosporine after human pulmonary transplantation
20. Acute rejection of lung allografts with various immunosuppressive protocols
21. Long-term health status and quality of life outcomes of lung transplant recipients
22. The importance of bronchoscopy with transbronchial lung biopsy and bronchoalveolar lavage in the management of lung transplant recipients
23. The registry of the International Society for Heart and Lung Transplantation: Fifteenth official report - 1998
24. The registry of the International Society for Heart and Lung Transplantation: Sixteenth official report - 1999
25. The role of cardiopulmonary exercise testing in lung and heart-lung transplantation
26. Analysis of risk factors for the development of bronchiolitis obliterans
27. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts
28. Transplantation for pulmonary hypertension
29. International guidelines for the selection of lung transplant candidates
30. Blade balloon atrial septostomy in patients with severe primary pulmonary hypertension
31. Cytolytic therapy for the treatment of bronchiolitis obliterans syndrome following lung transplantation
32. Clinical significance or hyperbilirubinemia in patients with pulmonary hypertension undergoing heart-lung transplantation
33. The diagnosis of obliterative bronchiolitis after heart-lung and lung transplantation: Low yield of transbronchial lung biopsy
34. Recovery of the right ventricle after single-lung transplantation in pulmonary hypertension
35. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation
36. Primary pulmonary hypertension as a risk factor for the development of obliterative bronchiolitis in lung allograft recipients
37. Single lung transplantation for primary pulmonary hypertension
38. Ventilation-perfusion inequalities during graft rejection in patients undergoing single lung transplantation for primary pulmonary hypertension
39. Selective lung or heart-lung transplantation for pulmonary hypertension associated with congenital cardiac anomalies
40. Bronchiolitis obliterans in lung transplant recipients. The "thorn in the side" of lung transplantation
41. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension
42. Effect of orally active prostacyclin analogue on survival of outpatients with primary pulmonary hypertension
43. Timing of single lung transplantation for primary pulmonary hypertension
44. Pulmonary retransplantation: Predictors of graft function and survival in 230 patients
45. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension
46. Organ Procurement and Transplantation Network; final rule. 42 CFR Part 121
47. Organ Procurement and Transplantation Network; final rule. 42 CFR Part 121
48. Single lung transplantation for pulmonary hypertension: Single institution experience in 34 patients
49. Single-lung transplantation for pulmonary hypertension: Three-month hemodynamic follow-up
50. Physiologic definitions of obliterative bronchiolitis in heart-lung and double lung transplantation: A comparison of the forced expiratory flow between 25% and 75% of the forced vital capacity and forced expiratory volume in one second
51. The cost-effectiveness of lung transplantation: A pilot study
52. Improvement in quality of life after lung transplantation: A preliminary study
53. Heart-lung transplantation. Successful therapy for patients with pulmonary vascular disease
54. Usefulness of atrial septostomy as a treatment for primary pulmonary hypertension and guidelines for its application
55. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension
56. Echocardiographic characterization of the improvement in right ventricular function in patients with severe pulmonary hypertension after single-lung transplantation
57. FK506 'rescue' immunosuppression for obliterative bronchiolitis after lung transplantation
58. Graded balloon dilation atrial septostomy as a bridge to transplantation in primary pulmonary hypertension
59. Primary pulmonary hypertension
60. Adjuvant treatment of refractory lung transplant rejection with extracorporeal photopheresis
61. Atrial septostomy for pulmonary hypertension
62. Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension
63. Development of bronchiolitis obliterans syndrome in recipients of heart-lung transplantation-early risk factors
64. The role of transbronchial biopsies in the management of lung transplant recipients
65. Quality of well-being predicts survival in lung transplantation candidates
66. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation
67. The effect of lung transplantation on health-related quality of life. A longitudinal study
68. Diagnosis and management of rejection and bronchiolitis obliterans
69. Flexible bronchoscopy in lung transplantation
70. The role of transbronchial lung biopsy in the treatment of lung transplant recipients: An analysis of 200 consecutive procedures
71. Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis
72. Heart-lung transplantation for primary pulmonary hypertension
73. Mycophenolate mofetil for obliterative bronchiolitis syndrome after lung transplantation
74. A review of 23 human lung transplantations by 20 surgeons
75. Can transbronchial biopsy aid in the diagnosis of bronchiolitis obliterans in lung transplant recipients?